Erlander Mark 4
4 · Cardiff Oncology, Inc. · Filed Mar 10, 2022
Insider Transaction Report
Form 4
Erlander Mark
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2022-03-09+370,128→ 1,185,400 totalExercise: $2.50Exp: 2032-03-09→ Common Stock (370,128 underlying)
Footnotes (1)
- [F1]92,532 vest on 3/09/2023. 7,711 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026.